FeesSafety
Pluang+

China Medical System starts Phase III trial of oral drug Povorcitinib for vitiligo in China.

Market News
19 Nov 2026, 14:04 WIB
Globe News Wire
View Source
Bullish
China Medical System starts Phase III trial of oral drug Povorcitinib for vitiligo in China.

China Medical System's subsidiary Dermavon has enrolled the first patient in a Phase III clinical trial in China for Povorcitinib, an oral JAK1 inhibitor targeting non-segmental vitiligo. The multi-center, randomized, double-blind study will involve about 174 patients across 44 centers to evaluate the drug's safety and efficacy. Povorcitinib has been designated a Breakthrough Therapeutic Drug by China's NMPA, potentially speeding its approval. If successful, it could offer a new systemic treatment option for millions of Chinese vitiligo patients, complementing Dermavon's existing topical drug Lumirix® and addressing significant unmet medical needs.

China Medical System’s clinical trial for Povorcitinib provides context for health sector activity on Pluang as of Nov 19, 2026, 18:12 WIB. Among 150 health-sector US stocks, 79 rose and 64 fell. Dyne Therapeutics (DYN) gained 3.97% to USD 16.50, contrasting with Haleon (HLN) which dropped 3.96% to USD 8.72, while Recursion Pharmaceuticals (RXRX) rose 3.36% to USD 2.92 with a buy order activity of 63% and a typical hold time of 23 days.

More News

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works reported third-quarter earnings per share of $0.26, surpassing the $0.12 estimate, and revenue of $1.58 billion, above the $1.55 billion estimate. The company also announced a new $500 million share repurchase program and raised its...

Company Fundamentals
Bullish
52 minutes ago
Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal has integrated its neutral-atom quantum processors natively into Slurm's Hierarchical Resources (HRES) system, recently expanded by NVIDIA. This allows supercomputing centers to manage quantum processing units (QPUs) alongside CPUs and GPUs mo...

Market News
Bullish
56 minutes ago
SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX currently earns most of its profits from its Starlink satellite internet service, which has 13.6 million subscribers and generated $2.37 billion in operating income last quarter. However, the company is aggressively pivoting towards artificial...

Market News
Bullish
1 hour ago
TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

Despite a recent 25% drop in semiconductor stocks, TSMC and Applied Materials stand out due to their dominant market positions and growth potential. TSMC leads with a 73% share in the foundry market, benefiting from AI chip demand and planned price h...

Market News
Bullish
1 hour ago
Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

The stock market is vulnerable to a sharp correction due to rising interest rates and uncertainty in the AI industry following Nvidia CEO Jensen Huang's departure amid scandal. Inflation pressures have led the Federal Reserve to raise rates, potentia...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App